Christopher R. Holroyd1, Rakhi Seth1, Marwan Bukhari2, Anshuman Malaviya3, Claire
Holmes1, Elizabeth Curtis4, Christopher Chan1, Mohammed A. Yusuf3, Anna Litwic4, 5 …

Introduction: Biological drugs are therapies designed to target a specific molecule of the
immune system that have been linked with the development of autoimmune diseases. Areas …

Objective To describe the clinical characteristics, histopathologic features, and outcomes of
patients in whom vasculitis developed in association with use of tumor necrosis factor-α …

Rheumatoid vasculitis is a rare but serious complication of rheumatoid arthritis. Herein we
examine the pathophysiology, epidemiology, clinical diagnosis, and treatment of rheumatoid …

Objectives To develop and/or update fact sheets about TNFα antagonists treatments, in
order to assist physicians in the management of patients with inflammatory joint disease …

Biological agents represent a major advance in the treatment of rheumatic diseases, most
particularly in the prevention of irreversible structural damage. While generally well …

Objective. To test the efficacy of treatment with rituximab in refractory rheumatoid vasculitis in
patients with rheumatoid arthritis (RA). Methods. Retrospective study of four female patients …

Vasculitis has been described in most types of inflammatory arthritis. The best described and
most widely recognised form is rheumatoid vasculitis. The incidence of systemic rheumatoid …

Vasculitis is defined as an inflammatory cell infiltration and destruction of blood vessels
identified upon histologic examination. Cutaneous manifestations are frequent during the …

Post-COVID-19 (PC) and post-COVID-19 vaccination (PCV) syndromes are considered
emergent multidisciplinary disorders. PC/PCV small fiber neuropathy (SFN) was rarely …